Cite

HARVARD Citation

    Barclay, S. et al. (n.d.). Safety and Efficacy of a tCD25 Preselective Combination Anti‐HIV Lentiviral Vector in Human Hematopoietic Stem and Progenitor Cells. Stem cells. pp. 870-879. [Online]. 
  
Back to record